Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience
Eleonora De Bellis, Silvia Imbergamo, Anna Candoni, Albana Liço, Ilaria Tanasi, Endri Mauro, Federico Mosna, Matteo Leoncin, Manuela Stulle, Davide Griguolo, Stefano Pravato, Livio Trentin, Davide Lazzarotto, Eros Di Bona, Renato Bassan, Elisa Lucchini, Monica Poiani, Clara Palmieri, Francesco Zaja
Topics & Concepts
MedicineVenetoclaxDecitabineInternal medicineAzacitidineMyeloid leukemiaHypomethylating agentHematologyNeutropeniaGastroenterologyLeukemiaOncologyChemotherapyChronic lymphocytic leukemiaGeneChemistryBiochemistryDNA methylationGene expressionAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentHematopoietic Stem Cell Transplantation